Position in ALGS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$566,515
-$144,107 QoQ
Shares Held
76,247
0.0% QoQ
Ownership
2.13%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ALGS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026HHLR ADVISORS, LTD. holds $546,432,817 across 9 Biotechnology names. ALGS ranks #9 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
1,034,306 | $307,157,852 | |
| 2 | LEGN |
Legend Biotech Corp
|
5,984,550 | $108,260,509 | |
| 3 | AVBP |
ArriVent BioPharma, Inc.
|
3,929,117 | $90,644,729 | |
| 4 | NBP |
NovaBridge Biosciences
|
5,980,568 | $14,712,197 | |
| 5 | MAZE |
Maze Therapeutics, Inc.
|
366,028 | $10,925,935 | |
| 6 | CTNM |
Contineum Therapeutics, Inc.
|
669,337 | $8,741,541 | |
| 7 | SGMT |
Sagimet Biosciences Inc.
|
724,800 | $3,787,080 | |
| 8 | GOSS |
Gossamer Bio, Inc.
|
4,974,041 | $1,636,459 |
All Filings in ALGS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $566,515 | 76,247 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $710,622 | 76,247 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $747,220 | 76,247 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $549,740 | 76,247 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $629,037 | 76,247 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $3,037,680 | 76,247 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $660,299 | 76,247 | Shares | Other | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||